Bright Minds Biosciences invites you to their event

Opioid Use Disorder Study Presentation

About this event

Bright Minds Chief Medical Officer, Dr. Revati Shreeniwas and Bright Minds collaborator and world renown addiction researcher Dr. Kathy Cunningham of University of Texas Medical Branch will be discussing the findings of our pre-clinical trial evaluating the efficacy of our 5-HT2c program to treat Opioid Use Disorder in a brief 10 minute webinar.

Hosted by

  • Team member
    BM T
    Bright Minds

Bright Minds Biosciences

Healing the brain

We are a biotechnology company dedicated to developing next-generation therapeutics to improve the lives of patients with severe and life-altering brain diseases.